Resumen
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.)
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 1018-1023 |
| Número de páginas | 6 |
| Publicación | JACC: Case Reports |
| Volumen | 3 |
| N.º | 7 |
| DOI | |
| Estado | Published - jul 7 2021 |
Nota bibliográfica
Publisher Copyright:© 2021 The Authors
Financiación
This work was supported by American Heart Association (grant #18CDA34110361; LAB, 2018). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
| Financiadores | Número del financiador |
|---|---|
| American the American Heart Association | 18CDA34110361 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Huella
Profundice en los temas de investigación de 'Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver